IRESF:OTC-iShares Public Limited Company - iShares Core FTSE 100 UCITS ETF (USD)

ETF | Others |

Last Closing

USD 7

Change

-0.50 (-6.67)%

Market Cap

N/A

Volume

867.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

+4.68 (+0.78%)

USD 32.85B
ZKBGF ZKB Gold ETF

N/A

USD 8.96B
TOETF Tosei Corporation

N/A

USD 7.70B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
EBCRY EBCRY

+0.81 (+8.58%)

USD 3.18B
SSEEF SSgA SPDR ETFs Europe I Public..

N/A

USD 2.95B
IFXAF iShares Asia Trust - iShares F..

N/A

USD 2.94B
ZKBHF ZKB Gold ETF

N/A

USD 2.93B
GDRPF Golden Resources Development I..

N/A

USD 2.70B
ISRPF iShares Public Limited Company..

N/A

USD 2.22B

ETFs Containing IRESF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.55% 23% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.55% 20% F 53% F
Trailing 12 Months  
Capital Gain 3.31% 22% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.31% 23% F 56% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.95% 66% D+ 54% F
Dividend Return 9.95% 65% D 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.14% 73% C 96% N/A
Risk Adjusted Return 98.09% 99% N/A 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike